Next Article in Journal
Multi-Level Processes and Retina–Brain Pathways of Photic Regulation of Mood
Next Article in Special Issue
Analysis of Factors That May Affect the Effectiveness of Ketogenic Diet Treatment in Pediatric and Adolescent Patients
Previous Article in Journal
Evolution of Hypodensity on Non-Contrast CT in Correlation with Collaterals in Anterior Circulation Stroke with Successful Endovascular Reperfusion
Previous Article in Special Issue
Comparison of Acute Withdrawal and Slow Taper of Antiseizure Medications during Video Electroencephalographic Monitoring: Efficacy for Shortening of Hospital Stay
 
 
Article
Peer-Review Record

Involvement of Peripheral Monocytes with IL-1β in the Pathogenesis of West Syndrome

J. Clin. Med. 2022, 11(2), 447; https://doi.org/10.3390/jcm11020447
by Tomoko Takamatsu *, Gaku Yamanaka, Koko Ohno, Kanako Hayashi, Yusuke Watanabe, Mika Takeshita, Shinji Suzuki, Shinichiro Morichi, Soken Go, Yu Ishida, Shingo Oana, Yasuyo Kashiwagi and Hisashi Kawashima
Reviewer 1: Anonymous
Reviewer 2:
J. Clin. Med. 2022, 11(2), 447; https://doi.org/10.3390/jcm11020447
Submission received: 18 November 2021 / Revised: 2 January 2022 / Accepted: 14 January 2022 / Published: 16 January 2022
(This article belongs to the Special Issue Current Challenges and Advances in the Treatment of Epilepsy)

Round 1

Reviewer 1 Report

The objective of the manuscript was to examine the intracellular cytokine profiles of peripheral blood cells collected from 13 patients with WS using flow cytometry and measured their serum cytokine levels. The authors found a higher percentages of interleukin-1β (IL-1β), interleukin-1 receptor antagonist (IL- 20 1RA)-positive monocytes, and interferon gamma (IFN-γ) in CD8+ T cells. There was no correlation 23 between the ratios of positive cells and the serum levels of a particular cytokine in WS patients.

The justification to study cytokines in WS is superficial. The introduction only focus on IL-beta. More elaboration of the role of cytokine in WS is needed if the goal is focusing in cytokine profiles.  What happened with other cytokines in WS, why focus on IL-1beta? How the IL-beta is affected by the course of the disease or treatment? How and when the IL-beta show high levels compare with controls?

Also, CSF samples should be included in the analysis to determine peripheral and neural IL-1 related with WS.

How antiepileptic drugs of VIT B6 were analyzed as confounding factor?

Any difference among different causes of WS? A table showing values in each patient has an important value to further studies (e.i. meta-analysis etc...)

Other cytokines should be described in the main text and not as supplementary information.

Is there any correlation between cell-surface makers CD3, CD4, and CD8, CD14, CD25, and 102 CD69 and cytokine levels?

What are the levels of those cytokine in those patients during interictal periods?

What is the discussion about IP-10 and IL-6 levels? This is a contradiction with some statement in discussion (line 170)

Explanation of TNF difference among groups is needed.

Author Response

Please see the attachment." in the box if you only upload an attachment

Author Response File: Author Response.docx

Reviewer 2 Report

Major 

  1. The authors should provide literature review of older studies where they studies cytokines profile of patients with West Syndrome before and after treatment with ACTH.
  2. The authors should discuss and compare findings of this studies with other studies where they explored the role of immunogenicity and inflammatory pathways for pathogenicity of West Syndrome.

Minor points 

  1. The authors should consider changing following line to make it more specific than generalization. "some cytokines have been associated with epilepsy".

Author Response

Please see the attachment

Author Response File: Author Response.docx

This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.


Back to TopTop